Previous close | 1,819.00 |
Open | 1,818.00 |
Bid | 1,810.00 x 0 |
Ask | 2,222.00 x 0 |
Day's range | 1,804.00 - 1,838.00 |
52-week range | 1,711.00 - 2,222.00 |
Volume | |
Avg. volume | 624,802 |
Market cap | 4.023B |
Beta (5Y monthly) | 0.44 |
PE ratio (TTM) | 26.28 |
EPS (TTM) | 0.69 |
Earnings date | 22 Feb 2024 |
Forward dividend & yield | 0.57 (3.13%) |
Ex-dividend date | 21 Mar 2024 |
1y target est | 22.89 |
Key Insights Significantly high institutional ownership implies Hikma Pharmaceuticals' stock price is sensitive to...
I want to increase my exposure to the pharmaceuticals industry this year, so I've been looking for undervalued stocks to buy with strong growth potential. The post I’m considering these 3 undervalued pharma stocks to buy for my portfolio in April appeared first on The Motley Fool UK.
Our writer details two FTSE 100 shares that she thinks could help build a great portfolio of stocks to boost long-term wealth. The post 2 FTSE 100 shares investors should consider buying for a winning portfolio appeared first on The Motley Fool UK.